Dr Andrew Rynne.
The news emerging about Testosterone Replacement Therapy (TRT) keeps getting better all the time. Recent published clinical trials show benefit for this treatment far beyond boosting libido or reducing erectile dysfunction. It is now becoming apparent that TRT has the potential to not only prolong life but to also improve the quality of that prolonged life. In addition to this exciting news, criteria for deciding who might benefit from this treatment have been greatly simplified. And yet, for reasons that I will try and explain later, most doctors remain opposed to this potentially life saving treatment.
It has now been shown unequivocally that by raising testosterone levels in your blood you can:
Ø Reduce insulin requirements in people suffering from type 2 diabetes.
Ø Reduce blood lipid levels and thus the need to take medications for this purpose.
Ø Improve coronary artery disease and its symptoms of angina pectoris.
Ø TRT also reduces visceral fat or “pot belly” so common in older men.
Ø Cognitive function or brain power is improved by keeping testosterone levels up.
Up to a few years ago, it was common practise for those seeking testosterone replacement therapy that they be required to undergo a range of expensive and not altogether reliable hormonal assays. Recently it has emerged that not only were these tests not necessary but also that they added nothing to the decision making process as to whether one might benefit from TRT or not. Today, most enlightened doctors, rely on presenting symptoms and complaints, not on blood tests, when making this decision.
In spite of all these clinically proven advantages for taking TRT must doctors remain opposed to it today. This is due to their harbouring deeply ingrained erroneous notions about raised testosterone levels and the incidence of prostate cancer. Metastatic prostate cancer may be temporarily checked by reducing testosterone levels to zero. This however does not mean that the corollary is true, that raised testosterone increase the incidence of prostate cancer. Clinical studies designed to show this to be the case have all failed to do so. Prostate cancer is a disease of older men with declining testosterone levels and to suggest that raised levels could in any way increase prostate disease is to fly in the face of reason and science.
I believe that as time goes on TRT will eventually become mainstream treatment for some men troubled by their ageing process. In the meantime, if you would like to know more about this exciting subject, then please visit my website and ask me any questions that you might have. It would be my privilege to try and help you. Thank you for your interest.
Find out more about Testosterone Replacement Therapy at www.doctorrynne.com